🟢 20/20 Biolabs is trading 11.06% up today — no confirmed company-specific catalyst

20/20 Biolabs is trading 11.06% higher at $0.47, with no confirmed company-specific catalyst identified.

• No reliable company-specific announcement dated September 25, 2026, was identified.
• Earlier disclosures included Nasdaq compliance deficiencies and approval to increase authorized shares, but available coverage does not establish either as the direct cause of the intraday gain.
• Broader indices are modestly higher, but below the stated threshold for a strong market explanation.